[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100491739":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":27,"locations":35,"responsibleParty":56,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"University Hospital, Ghent","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"intrauterine gel application","EXPERIMENTAL","Application of Hyalobarrier intrauterine after myomectomy.",[13],"Device: Hyalobarrier",{"label":15,"type":16,"description":17,"interventionNames":18},"no intra-uterine gel application","NO_INTERVENTION","No application of Halobarrier intrauterine after myomectomy.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Hyalobarrier","Hyalobarrier is a viscous, transparent gel and is used as a preventive measure for post-operative adhesions in the abdominal and uterine cavity.",[9],[26],"anti-adhesive gel",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":18,"email":32},"Steffi Van Wessel, Dr.","CONTACT","093320758","studieco.vrouwenkliniek@uzgent.be",{"name":34,"role":30,"phone":31,"phoneExt":18,"email":32},"Steven Weyers, Prof. dr.",[36],{"facility":37,"status":38,"city":39,"state":18,"zip":18,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University Hospital Ghent","RECRUITING","Ghent","Belgium","BE",{"type":43,"coordinates":44},"Point",[45,46],3.71667,51.05,{"lat":46,"lon":45},[49,51,53],{"name":50,"role":30,"phone":31,"phoneExt":18,"email":18},"Steffi van Wessel, Dr.",{"name":52,"role":30,"phone":31,"phoneExt":18,"email":18},"Steven Weyers, Prof. Dr.",{"name":54,"role":55,"phone":18,"phoneExt":18,"email":18},"Steffi van Wessel","PRINCIPAL_INVESTIGATOR",{"type":57,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[59],{"name":60,"class":61},"Nordic Pharma SAS","INDUSTRY","100491739","prevention-of-intra-uterine-adhesions-following-laparoscopic-and-laparotomic-myomectomy-100491739",false,"NCT05683041","Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy","PALLM","Inclusion Criteria:\n\n* age between 18 and 45 years.\n* intramurale and\u002For subserosal myoma (FIGO 3-6), and\u002For hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic \u002F laparotomic myomectomy.\n* absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy\n\nExclusion Criteria:\n\n* pregnancy.\n* laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy.\n* presence of endometritis.\n* other antiadhesion methods",true,"FEMALE","18 Years","45 Years",{"count":74,"type":75},30,"ESTIMATED","INTERVENTIONAL",[78],"NA","Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy.\n\nMyomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.",[81],"Myoma",[83,84,85,86,87,88,89],"Postoperative adhesions","Intrauterine adhesions","Myomectomy","Laparoscopic myomectomy","Laparotomic myomectomy","Adhesion prevention","Antiadhesion method","2025-01-22",{"date":92,"type":93},"2025-01-27","ACTUAL",{"date":95,"type":93},"2023-02-22",{"date":97,"type":75},"2028-01",{"name":5,"class":6},1]